Results 13,401-13,420 of 21,090 for speaker:Alan Kelly

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: I know the whole process. It takes a couple of years but all of that was skipped in this instance.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: I understand that and I agree that it will be across Europe. In terms of the women affected, it will work for some but not for others. I am not saying that this is a miracle drug in any way, shape or form but it seems to be helping Vicky Phelan, with whom I am in contact a lot. In other cases, it may not help but all of these women will do anything they can, regardless of whether they are...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: I thank Professor Barry for his honesty.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: I appreciate the Professor's honesty.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: That did not happen in this case.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: I am aware of that and Dr. Fennelly and Professor Crown have written about it. I understand that it can be done off-licence. The issue here is that it costs €8,500 every three weeks and the State is paying for it. I invite Mr. Judge to respond.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: I am interested in Mr. Judge's view on that specific point.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: Did that happen with Orkambi?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: The Minister intervened in the process by way of the clause to which Mr. Judge referred.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: The Minister can have a role here.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: In fairness to Mr. Judge, I know he is in a difficult situation as a representative of the Department but, in a roundabout way, that means that the Minister intervened in this scenario. As many of my colleagues have said, most notably Deputy Brassil, political pressure creates the conditions which allow the Minister to intervene. That is just reality. Professor Barry has been very open and...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: What is going to happen? How can we distinguish between two sets of women? There is a woman in Galway-----

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: It is pretty clear that we have an issue here that must be addressed.

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: On amendment No. 11, I agree with the Minister about changing the review period to three years. A number of us are glad that the Minister listened on that issue. Five years was certainly the wrong timeframe. I support amendment No. 12. It is a good amendment because God knows we have issues in respect of proper data collection when it comes to healthcare. The specifications set out are...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I want to speak to amendment No. 32 in my name. It is very similar to amendment No. 33. The Minister should listen to the previous speakers. I agree wholeheartedly with what they have said. The three-day period was in the heads of the Bill, we have to accept that. How it got in there we can possibly debate another time. It is a barrier for all the reasons that have been stated. If we...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I shall speak to amendment No. 20 which is very similar to amendment No. 19. Page 9 of the Bill contains the section which deals with "Risk to life or health". Section 11(1)( c ) contains the word "avert", as Deputy Clare Daly has outlined; perhaps other Deputies have, too. The use of the word "avert" is too absolute. I have spoken to the Minister about this issue before. Section 11(1)(...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I will be withdrawing amendments Nos. 24 and 26, based on the clarification the Minister gave me earlier. However, I believe it is important the amendments were put down because they have brought about a clearer thought process and changes that have improved the Bill. The fact of the non-requirement for a time period makes a difference, as well as what has been explained to me in regard to...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I move amendment No. 26:In page 10, to delete lines 23 to 28 and substitute the following: “(4) The obstetrician referred to in paragraph (a)of subsection (2)shall make such arrangements as he or she shall deem to be necessary for the carrying out as soon as may be of the termination of pregnancy to which the certification referred to in subsection (3)relates.”. Based on...

Public Accounts Committee: Business of Committee (29 Nov 2018)

Alan Kelly: That is across different local authorities, of course.

Public Accounts Committee: Business of Committee (29 Nov 2018)

Alan Kelly: According to the correspondence, HIQA is dealing with the agency issue and has the resources to do it. That is great but let us see if it is actually happening. Significant issues were there previously.